Cargando…
Cross communication of diet-microbiome-immune interactions in cancer immunotherapy
Simpson et al. have highlighted a diet-driven microbiome community, which paves the way for landmark therapeutic avenues for facilitating efficacy and minimizing immune-related adverse events during neoadjuvant immune checkpoint inhibitor treatment in melanoma patients. This innovative attempt inspi...
Autores principales: | Zhou, Cheng-Bei, Fang, Jing-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729813/ https://www.ncbi.nlm.nih.gov/pubmed/36384089 http://dx.doi.org/10.1016/j.xcrm.2022.100806 |
Ejemplares similares
-
Two types of biomarker-dependent chemo-immunotherapy for pancreatic cancer?
por: Melief, Cornelis J.M.
Publicado: (2022) -
Unraveling the mechanisms of IVIG immunotherapy in MIS-C
por: Ganigara, Madhusudan, et al.
Publicado: (2021) -
Are changes in the gut microbiome a contributor or consequence of autism—why not both?
por: Özcan, Ezgi, et al.
Publicado: (2022) -
Too much water drowned the miller: Akkermansia determines immunotherapy responses
por: Li, Le, et al.
Publicado: (2022) -
Spiking immunotherapy with a bacterial cocktail brings T cells back to the fight
por: Greathouse, K. Leigh, et al.
Publicado: (2021)